IMMUNOGENIC FUSION POLYPEPTIDES

In one aspect, the invention relates to an isolated polypeptide including the amino acid sequence of a carrier polypeptide and the amino acid sequence of an ORF2086 polypeptide. In another aspect, the invention relates to an immunogenic conjugate including ORF2086 polypeptide and a carrier polypepti...

Full description

Saved in:
Bibliographic Details
Main Authors JANSEN, KATHRIN UTE, MORAN, JUSTIN KEITH, RUPPEN, MARK EDWARD, DILTS, DEBORAH ANN, VIDUNAS, EUGENE JOSEPH, ANDERSON, ANNALIESA SYBIL
Format Patent
LanguageEnglish
French
Published 09.04.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In one aspect, the invention relates to an isolated polypeptide including the amino acid sequence of a carrier polypeptide and the amino acid sequence of an ORF2086 polypeptide. In another aspect, the invention relates to an immunogenic conjugate including ORF2086 polypeptide and a carrier polypeptide. The invention further includes immunogenic compositions and methods for inducing an immune response against Neisseria meningitidis in a mammal. Dans un aspect, l'invention concerne un polypeptide isolé comprenant la séquence d'acides aminés d'un polypeptide support et la séquence d'acides aminés d'un polypeptide ORF2086. Dans un autre aspect, l'invention concerne un conjugué immunogène comprenant un polypeptide ORF2086 et un polypeptide support. L'invention concerne en outre des compositions immunogènes et des procédés d'induction d'une réponse immunitaire contre Neisseria meningitidis chez un mammifère.
Bibliography:Application Number: CA20142903716